Hostname: page-component-5c6d5d7d68-thh2z Total loading time: 0 Render date: 2024-08-13T00:22:33.657Z Has data issue: false hasContentIssue false
  • English
  • Français

3-Methyl-4-Chlorophenol for Prion Decontamination of Medical Devices

Published online by Cambridge University Press:  21 June 2016

Constanze Riemer ,
Theresa Bamme ,
Simon Wing Fai Mok  and
Michael Baier
Constanze Riemer
Affiliation:
Robert-Koch-Institut, Nordufer, Germany
Theresa Bamme
Affiliation:
Robert-Koch-Institut, Nordufer, Germany
Simon Wing Fai Mok
Affiliation:
Robert-Koch-Institut, Nordufer, Germany
Michael Baier*
Affiliation:
Robert-Koch-Institut, Nordufer, Germany
*
Project “Neurodegenerative Diseases”, Robert-Koch-Institut, Nordufer 20, 13353 Berlin, Germany (baierm@rki.de)
Get access Rights & Permissions [Opens in a new window]

Abstract

Disinfectants containing 3-methyl-4-chlorophenol were tested for their capacity to inactivate the infectious agent of scrapie. Coincubation of brain homogenates prepared from terminally ill scrapie-infected hamsters with the disinfectants rendered the prion protein PrPSc sensitive to proteinase K digestion. Inoculation of hamsters with disinfectant-treated samples indicated a reduction in infectivity levels to below the limit of detection.

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 27 , Issue 7 , July 2006 , pp. 778 - 780
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Taylor, DM. Inactivation of transmissible degenerative encephalopathy agents: a review. Vet J 2000; 159:10–17.Google Scholar
2. Bernoulli, C, Siegfried, J, Baumgartner, G, Regli, F, Rabinowicz, T, Gajdusek, DC, Gibbs, CJ Jr. Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery. Lancet 1977; 1:478–479.Google Scholar
3. Collins, S, Law, MG, Fletcher, A, Boyd, A, Kaldor, J, Masters, CL. Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study. Lancet 1999; 353:693–697.Google Scholar
4. Wadsworth, JD, Joiner, S, Hill, AF, Campbell, TA, Desbruslais, M, Luthert, PJ, Collinge, J. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet 2001; 358:171–180.Google Scholar
5. Glatzel, M, Abela, E, Maissen, M, Aguzzi, A. Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. N Engl J Med 2003; 349:1812–1820.CrossRefGoogle ScholarPubMed
6. Jackson, GS, McKintosh, E, Flechsig, E, et al. An enzyme-detergent method for effective prion decontamination of surgical steel. J Gen Virol 2005; 86:869–878.CrossRefGoogle ScholarPubMed
7. Race, RE, Raymond, GJ. Inactivation of transmissible spongiform encephalopathy (prion) agents by environ LpH. J Virol 2004; 78:2164–2165.CrossRefGoogle ScholarPubMed
8. Baier, M, Schwarz, A, Mielke, M. Activity of an alkaline “cleaner” in the inactivation of the scrapie agent. J Hosp Infect 2004; 57:80–84.Google Scholar
9. Baier, M, Norley, S, Schultz, J, Burwinkel, M, Schwarz, A, Riemer, C. Prion diseases: infectious and lethal doses following oral challenge. J Gen Virol 2003; 84:1927–1929.Google Scholar
10. McKinley, MP, Bolton, DC, Prusiner, SB. A protease-resistant protein is a structural component of the scrapie prion. Cell 1983; 35:57–62.CrossRefGoogle ScholarPubMed
11. Fichet, G, Comoy, E, Duval, C, et al. Novel methods for disinfection of prion-contaminated medical devices. Lancet 2004; 364:521–526.Google Scholar
12. Baxter, HC, Campbell, GA, Whittaker, AG, et al. Elimination of transmissible spongiform encephalopathy infectivity and decontamination of surgical instruments by using radio-frequency gas-plasma treatment. J Gen Virol 2005; 86:2393–2399.Google Scholar
13. Bertram, J, Mielke, M, Beekes, M, Lemmer, K, Baier, M, Pauli, G. Inactivation and removal of prions in producing medical products: a contribution to evaluation and declaration of possible methods [in German]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2004; 47:36–38.Google Scholar
14. Yan, Z-X, Stitz, L, Heeg, P, Pfaff, E, Roth, K. Infectivity of prion protein bound to stainless steel wires: a model for testing decontamination procedures for transmissible spongiform encephalopathies. Infect Control Hosp Epidemiol 2004; 25:280–283.Google Scholar
15. Organisation for Economic Co-operation and Development (OECD) guidelines for testing of chemicals. Ready biodegradability assay: modified Sturm test. OECD no. 301 B. Paris: OECD; 1981.Google Scholar